Team PHenomenal Hope will host its inaugural symposium — PHenomenal Hope 2023: Knowledge, Research & Advocacy in PH —…
Articles by Andrea Lobo
Treatment with levosimendan — a medication seen to improve cardiac function — was associated with rapid clinical benefits in…
Among people with pulmonary arterial hypertension (PAH), a measure of artery deformity called pulmonary artery longitudinal strain may be…
The Pulmonary Hypertension Association (PHA) will join together with more than 80 organizations worldwide on May 5 for World…
Blood levels of a protein called thrombospondin-2 (TSP2) — related to clinically identifiable measures of right heart structure and function…
Tenax Therapeutics is planning to start a Phase 3 clinical trial of TNX-103 — oral levosimendan — to treat…
A long noncoding RNA molecule (lncRNA) — a long segment of RNA that regulates protein production in the body —…
Referral to a specialized chronic thromboembolic pulmonary hypertension (CTEPH) center for follow-up treatment after a pulmonary embolism (PE) —…
The development program of AER-901, Aerami Therapeutics’ inhaled formulation of imatinib, will include pulmonary hypertension associated with interstitial…
A peptide called apelin-17 may be used as a diagnostic biomarker for idiopathic pulmonary arterial hypertension (IPAH), according to…
Treatment with swietenine — extracted from the seeds of Swietenia macrophylla, a tree commonly called mahogany — eased the remodeling of lung…
Pulmonary arterial hypertension (PAH) is associated with high utilization of healthcare resources by patients and with productivity loss, starting…